Cervical Cancer

Specific subtype marks VEGF link to tumor invasion and low survival

Published in Women's Health Weekly, April 25th, 2002

by Sonia Nichols, senior medical writer - An examination of several cervical cancer tumors and cell lines has yielded new information about the significance of a specific form of vascular endothelial growth factor to tumor invasion and patient survival.

The study of vascular endothelial growth factor (VEGF) has gained importance in recent years due to its influence on tumor progression. It primarily functions to modulate the formation of new blood vessels, whether they be in tumors, cardiac tissues, healing wounds, or the eye.

Presently, several research centers are assessing the role of VEGF in cancer pathology. Medical researchers in Japan have...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2002-04-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry